José María Mora-Gutiérrez1, Nuria Garcia-Fernandez1, M Fernanda Slon Roblero2, Jose A Páramo3, F Javier Escalada4, Danny Jj Wang5, Alberto Benito6, María A Fernández-Seara6,7. 1. Nephrology, Clínica Universidad de Navarra, Pamplona, Spain. 2. Nephrology, Navarra Hospital, Pamplona, Spain. 3. Atherosclerosis Research Laboratory, CIMA, University of Navarra, Pamplona, Spain. 4. Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain. 5. Laboratory of Functional MRI Technology (LOFT) Stevens Neuroimaging and Informatics Institute University of Southern California, Los Angeles, California, USA. 6. Radiology, Clínica Universidad de Navarra, Spain. 7. Adjunct Associate Professor of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Abstract
PURPOSE: To investigate whether arterial spin labeling (ASL) MRI could detect renal hemodynamic impairment in diabetes mellitus (DM) along different stages of chronic kidney disease (CKD). MATERIALS AND METHODS: Three Tesla (3T) ASL-MRI was performed to evaluate renal blood flow (RBF) in 91 subjects (46 healthy volunteers and 45 type 2 diabetic patients). Patients were classified according to their estimated glomerular filtration rate (eGFR) as group I (eGFR > 60 mL/min/1.73 m2 ), group II (60 ≥ eGFR>30 mL/min/1.73 m2 ), or group III (eGFR ≤ 30 mL/min/1.73 m2 ), to determine differences depending on renal function. Studies were performed at 3T using a 12-channel flexible body array combined with the spine array coil as receiver. RESULTS: A 28% reduction in cortical RBF was seen in diabetics in comparison with healthy controls (185.79 [54.60] versus 258.83 [37.96] mL/min/100 g, P < 3 × 10-6 ). Differences were also seen between controls and diabetic patients despite normal eGFR and absence of overt albuminuria (RBF [mL/min/100 g]: controls=258.83 [37.96], group I=208.89 [58.83], P = 0.0018; eGFR [mL/min/1.73 m2 ]: controls = 95.50 [12.60], group I = 82.00 [20.76], P > 0.05; albumin-creatinine ratio [mg/g]: controls = 3.50 [4.45], group I = 17.50 [21.20], P > 0.05). A marked decrease in RBF was noted a long with progression of diabetic nephropathy (DN) through the five stages of CKD (χ2 = 43.58; P = 1.85 × 10-9 ). Strong correlation (r = 0.62; P = 4 × 10-10 ) was obtained between RBF and GFR estimated by cystatin C. CONCLUSION: ASL-MRI is able to quantify early renal perfusion impairment in DM, as well as changes according to different CKD stages of DN. In addition, we demonstrated a correlation of RBF quantified by ASL and GFR estimated by cystatin C. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2017;46:1810-1817.
PURPOSE: To investigate whether arterial spin labeling (ASL) MRI could detect renal hemodynamic impairment in diabetes mellitus (DM) along different stages of chronic kidney disease (CKD). MATERIALS AND METHODS: Three Tesla (3T) ASL-MRI was performed to evaluate renal blood flow (RBF) in 91 subjects (46 healthy volunteers and 45 type 2 diabeticpatients). Patients were classified according to their estimated glomerular filtration rate (eGFR) as group I (eGFR > 60 mL/min/1.73 m2 ), group II (60 ≥ eGFR>30 mL/min/1.73 m2 ), or group III (eGFR ≤ 30 mL/min/1.73 m2 ), to determine differences depending on renal function. Studies were performed at 3T using a 12-channel flexible body array combined with the spine array coil as receiver. RESULTS: A 28% reduction in cortical RBF was seen in diabetics in comparison with healthy controls (185.79 [54.60] versus 258.83 [37.96] mL/min/100 g, P < 3 × 10-6 ). Differences were also seen between controls and diabeticpatients despite normal eGFR and absence of overt albuminuria (RBF [mL/min/100 g]: controls=258.83 [37.96], group I=208.89 [58.83], P = 0.0018; eGFR [mL/min/1.73 m2 ]: controls = 95.50 [12.60], group I = 82.00 [20.76], P > 0.05; albumin-creatinine ratio [mg/g]: controls = 3.50 [4.45], group I = 17.50 [21.20], P > 0.05). A marked decrease in RBF was noted a long with progression of diabetic nephropathy (DN) through the five stages of CKD (χ2 = 43.58; P = 1.85 × 10-9 ). Strong correlation (r = 0.62; P = 4 × 10-10 ) was obtained between RBF and GFR estimated by cystatin C. CONCLUSION:ASL-MRI is able to quantify early renal perfusion impairment in DM, as well as changes according to different CKD stages of DN. In addition, we demonstrated a correlation of RBF quantified by ASL and GFR estimated by cystatin C. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2017;46:1810-1817.
Authors: Aghogho Odudu; Fabio Nery; Anita A Harteveld; Roger G Evans; Douglas Pendse; Charlotte E Buchanan; Susan T Francis; María A Fernández-Seara Journal: Nephrol Dial Transplant Date: 2018-09-01 Impact factor: 5.992
Authors: Cesar A Romero; Glauber Cabral; Robert A Knight; Guangliang Ding; Edward L Peterson; Oscar A Carretero Journal: Am J Physiol Renal Physiol Date: 2017-10-04
Authors: Pottumarthi V Prasad; Lu-Ping Li; Jon M Thacker; Wei Li; Bradley Hack; Orly Kohn; Stuart M Sprague Journal: Am J Nephrol Date: 2019-01-22 Impact factor: 3.754
Authors: Lu-Ping Li; Jon M Thacker; Wei Li; Bradley Hack; Chi Wang; Orly Kohn; Stuart M Sprague; Pottumarthi V Prasad Journal: Am J Nephrol Date: 2021-01-28 Impact factor: 3.754
Authors: Marissa J DeFreitas; Chryso P Katsoufis; Juan C Infante; Michael L Granda; Carolyn L Abitbol; Alessia Fornoni Journal: Pediatr Nephrol Date: 2020-01-17 Impact factor: 3.714
Authors: Fabio Nery; Charlotte E Buchanan; Anita A Harteveld; Aghogho Odudu; Octavia Bane; Eleanor F Cox; Katja Derlin; H Michael Gach; Xavier Golay; Marcel Gutberlet; Christoffer Laustsen; Alexandra Ljimani; Ananth J Madhuranthakam; Ivan Pedrosa; Pottumarthi V Prasad; Philip M Robson; Kanishka Sharma; Steven Sourbron; Manuel Taso; David L Thomas; Danny J J Wang; Jeff L Zhang; David C Alsop; Sean B Fain; Susan T Francis; María A Fernández-Seara Journal: MAGMA Date: 2019-12-12 Impact factor: 2.533